Abstract
The synthesis of [Phe(p-CH2SO3Na)52, Nle32,53,56 Nal55]-CCK20–58, [Tyr52, Nle32,53,56, Nal55]-CCK-58 and of [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK-58 using the (9-fluorenylmethyloxy)-carbonyl (Fmoc) strategy on a 2,4-DMBHA resin is described. The crude peptide preparations were extremely complex when analyzed by RP-HPLC, capillary zone electrophoresis (CZE), and ion-exchange chromatography (IE-FPLC). We found that the most effective strategy for purification included cation-exchange chromatography followed by a RP-HPLC desalting step. The highly purified peptides (purity greater than 90%) were characterized by RP-HPLC, size exclusion HPLC (SEC), IE-FPLC, CZE, mass spectrometry, amino acid analysis, and Edman sequence analysis {for [Tyr52, Nle32,53,56, Nal55]-CCK-58}. The results demonstrate the applicability of the 2,4-DMBHA resin for Fmoc solid-phase synthesis of long peptides amides (58 residues in length in this case) as well as the efficacy of an FPLC/RP-HPLC approach for the purification of very long, heterogeneous crude peptides, allowing a true assessment of the biological properties of these analogs to be carried out. [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK20–58 was less than 1% as potent as CCK-8 while [Tyr52, Nle32,53,56, Nal55]-CCK-58 and [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK-58 were inactive at the doses tested (<0.01%).
Similar content being viewed by others
References
Burgus, R. and Rivier, J. (1976). In: Loffet A (ed)., Peptides 1976. Bruxelles, Belgium: Editions de l'Universite, pp. 85–94.
Clarke-Lewis, I., Aebersold, R., Ziltener, H., Schrader, J. W., Hood, L. E., and Kent, S. B. H. (1986).Science 231 134–139.
Crawley, J. N., Stivers, J. A., Blumstein, L. K., and Paul, S. M. (1985).J. Neurosci. 5 1972–1983.
Dockray, G. J., Gregory, R. A., and Hutchinson, J. B. (1978).Nature 270 359–361.
Eng, J., Li, H.-R., and Yalow, R. S. (1990).Regul. Pept. 30 15–19.
Eysselein, V. E., Eberlein, G. A., Hesse, W. H., Singer, M. V., Goebell, H. and Reeve, J. R., Jr. (1987).J. Biol. Chem. 262 214–217.
Eysselein, V. E., Eberlein, G. A., Shaeffer, M., Grandt, D., Goebell, H., Niebel, W., Rosenquist, G. L., Meyer, H. E., and Reeve, J. R. (1990).Am. J. Physiol. G253–G260.
Eysselein, V. E., Reeve, J. R., Jr., Shively, J. E., Hawke, D., and Walsh, J. H. (1982).Peptides 3 687–691.
Fields, G. B., and Noble, R. L. (1990).Int. J. Peptide Protein Res. 35 161–214.
Hahn, K. W., Klis, W. A., and Stewart, J. M. (1990).Science 248 1544–1547.
Ivy, A. C., and Oldberg, E. (1928).Am. J. Physiol. 86 599–613.
Kaiser, E., Colescott, R. L., Bossinger, C. D., and Cook, P. I; (1970).Anal. Biochem. 34 595–598.
King, D. S., Fields, C. G., and Fields, G. B. (1990).Int. J. Peptide Protein Res. 36 255–266.
Kurano, Y., Kimura, T., and Sakakibara, S. (1987).J. Chem. Soc. Chem. Commun. 323–325.
Li, C. H., and Yamashiro, D. (1970).J. Am. Chem. Soc. 92 7608–7609.
Liddle, R. A., Elashoff, J., and Reeve, J. R., Jr., (1986).Peptides 7 723–727.
Liddle, R. A., Goldfine, I., Rosen, M. S., Taplitz, R. A., and Williams, J. A. (1985).J. Clin. Invest. 75 1144–1152.
Liddle, R. A., Goldfine, I. D., and Williams, J. A. (1984).Gastroenterology 87 542–549.
Lin, Y.-Z., Caporaso, G., Chang, P.-Y., Ke, X.-H., and Tam, J. P. (1988).Biochemistry 27 5640–5645.
Lin, Y.-Z., Isaac, D. D., and Tam, J. P. (1990).Int. J. Peptide Protein Res. 36 433–439.
Merrifield, R. B., (1963).J. Am. Chem. Soc. 85 2149–2154.
Miller, C., Hernandez, J.-F., Craig, A. G., Dykert, J., and Rivier, J. (1991). InAnal Chim Acta (Pardue, H. L., ed)., Elsevier Science Publishers, Amsterdam. The Netherlands,Vol. 249, pp. 215–225.
Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson I., Selk, L., Kent, S. B. H., and Wlodawer, A. (1989).Science 246 1149–1152.
Miranda, M. T. M., Liddle, R. A., and Rivier, J. E. (1993).J. Med. Chem. 36 1681–1687.
Morley, J. E. (1982).Life Sci. 30 479–493.
Mutt, V., and Jorpes, E. (1971).J. Biochem. 125 57P-58P.
Mutter, M., Tuchscherer, G., Miller, C., Altmann, K.-H., Carey, R. I., Wyss, D. F., Labhardt, A. M., and Rivier, J. E. (1992).J. Am. Chem. Soc. 114 1463–1470.
Nutt, R. F., Brady, S. F., Darke, P. L, Ciccarone, T. M., Colton, C. D., Nutt, E. M., Rodkey, J. A., Bennett, C. D., Waxman, L. H., Sigal, I. S., Anderson, P. S., and Veber, D. F. (1988).Proc. Natl. Acad. Sci. (USA) 85 7129–7133.
Penke, B., and Nyerges, L. (1991).Peptide Res. 4 289–295.
Penke, B. and Rivier, J. (1987).J. Orb. Chem. 52 1197–1200.
Penke, B., Zarándi, M., Zsigó, J., Tóth, G. K., Kovács, K., and Telegdy, G. (1987). InPeptides 1986, (Theodoropoulos, D., ed)., Walter de Gruyter, Berlin, 19th European Peptide Symposium, pp. 447–450.
Pinget, M., Straus, E., and Yalow, R. S. (1979).Life Sci. 25 339–342.
Reeve, J. R., Jr., Eysselein, V., Walsh, J. H., Ben-Avram, C. M., and Shively, J. E. (1986).J. Biol. Chem. 261 16,392–16,397.
Rivier, J. Miller, C., Spicer, M., Andrews, J., Porter, J., Tuchscherer, G., and Mutter, M. (1990). InInnovation and Perspectives in Solid Phase Synthesis (Epton, R., ed)., University of Oxford, Birmingham, pp. 39–50.
Rivier, J., Rivier, C., Spiess, J., and Vale, W. (1983).Analyt. Biochem. 127 258–266.
Skirboll, L. R., Grace, A. A., Hommer, D. W., Rehfeld, J., Goldstein, M., Hokfelt, T., and Bunney, B. S. (1981).Neuroscience 6 2111–2124.
Sun, G., Chang, T.-M., Xue, W., We, J. F. Y., Lee, K. Y., and Chey, W. Y. (1992).Am. J. Physiol 262 G35-G43.
Takahashi, Y., Kato, K., Hayashizaki, Y., Wakabayashi, T., Ohtsuka, E., Matsuki, S., Ikehara, M., and Matsubara, K. (1985).Proc. Natl. Acad. Sci. (USA) 82 1931–1935.
Tatemoto, K., Jörnvall, H., Siimesmaa, S., Halldén, G., and Mutt, V. (1984).FEBS Lett. 174 289–293.
Turkelson, C. M., Solomon, T. E., Bussjaeger, L., Turkelson, J. Ronk, M., Shively, J. E., Ho, F. J., and Reeve, J. R., Jr. (1988).Peptides 9 1255–1260.
Wandelen, C. V., Zeikus, R., and Tsou, D. (1989).MilliGen/Biosearch, Chemistry Update 1–16.
Williams, J. A. (1982).Biomed. Res. 3 107–121.
Yamashiro, D., and Li, C. H. (1978).J. Am. Chem. Soc. 100 5174–5179.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miranda, M.T.M., Grey Craig, A., Miller, C. et al. Total synthesis, purification, and characterization of human [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK20–58, [Tyr52, Nle32,53,56,Nal55]-CCK-58, and [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK-58. J Protein Chem 12, 533–544 (1993). https://doi.org/10.1007/BF01025118
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01025118